← Signal Board

Teladoc Health financial statements

텔러닥 헬스NYSE:TDOC · New York Stock Exchange · Healthcare · sector #17
$5.56-3.64%
2026-10-07 close

Teladoc Health's published financial data is dated 2026-10-04. 2024 revenue was $2.57B. 2024 operating profit was −$1.02B.

Reported results

Financial safety

Reference indicatorAs of 2024
Distress zoneFinancial-metric reference signal
Altman Z'' zoneZ'' -14.88
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
-14.88
Beneish M-Score
-4.37

No statistical flag

Sloan accrual
-36.82%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

3/9Weak

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score3/9

Profitability

  • Positive ROANot passed
  • Positive OCFPass
  • Improving ΔROANot passed
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioNot passed
  • No new sharesNot passed

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverPass

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Margin trendWarning

영업이익률 악화 (-9.6% → -39.7%, -30.2%p). 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
-39.7%
Interest coverage
-42.9x
Return on equity (ROE)
-67.1%

Operating margin −5pp

Operating loss
Interest coverageBase -42.9x adverse case -48.3x
Return on equity (ROE)Base -67.1% adverse case -78.7%

Revenue −15%

Interest coverage risk
Interest coverageBase -42.9x adverse case -36.5x
Return on equity (ROE)Base -67.1% adverse case -59.8%

Interest rate +2pp

Interest coverage risk
Interest coverageBase -42.9x adverse case -15.9x
Return on equity (ROE)Base -67.1% adverse case -72.8%

Interest coverage limit

Already below the limit by 40.7pp

Interest coverage limit at an operating margin of 0.9%

Interest expense coverage threshold

Teladoc Health notifications

Quantus Signal · live data · not investment advice · Privacy Policy